GAMC
NVS icon

Garner Asset Management Corp’s Novartis NVS Stock Holding History

Garner Asset Management Corp’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-840
Closed -$116K – 313
2025
Q4 		$116K Buy
+840
New +$110K 0.04% 181
2024
Q1 		– Sell
-1,015
Closed -$102K – 270
2023
Q4 		$102K Buy
+1,015
New +$98K 0.05% 158

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Garner Asset Management Corp's NVS Position: Q1 2026 in Review

Garner Asset Management Corp sold out of Novartis (NVS) in Q1 2026, closing a stake of 840 shares — an estimated $116K sold.

Garner Asset Management Corp first reported a position in NVS in Q4 2023 and held it in 2 quarters. The position peaked at $116K in Q4 2025. 1,604 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Garner Asset Management Corp reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
  • Garner Asset Management Corp sold 840 Novartis shares in Q1 2026, an estimated $116K.
  • Garner Asset Management Corp first reported a position in Novartis in Q4 2023 and held it in 2 quarters.
  • Garner Asset Management Corp's Novartis position peaked at $116K in Q4 2025.
  • 1,604 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Garner Asset Management Corp's 13F filing for Q1 2026, filed 29 Apr 2026.